We are live on ! Find out more
CTA

Chesley Taft & Associates Portfolio holdings

AUM $2.57B
1-Year Est. Return 22.93%
This Fund
S&P 500
This Quarter Est. Return
+3.19%
1 Year Est. Return
+22.93%
3 Year Est. Return
+80.85%
5 Year Est. Return
+97.37%
10 Year Est. Return
+353.09%
AUM
$975M
AUM Growth
-$14.4M
Cap. Flow
-$38.6M
Cap. Flow %
-3.96%
Top 10 Hldgs %
21.31%
Holding
250
New
7
Increased
71
Reduced
103
Closed
10

Top Sells

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$10.4M
2
LKQ icon
LKQ Corp
LKQ
+$9.52M
3
CVX icon
Chevron
CVX
+$6.29M
4
K
Kellanova
K
+$5.62M
5
DD
Du Pont De Nemours E I
DD
+$4.87M

Sector Composition

Rank Sector Weight
1 Healthcare 24.46%
2 Technology 14.05%
3 Industrials 13.72%
4 Consumer Staples 8.76%
5 Financials 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
26
State Street SPDR S&P 500 ETF Trust
SPY
$795B
$11.6M 1.19%
56,097
+1,343
+2% +$277K
DD
27
DELISTED
Du Pont De Nemours E I
DD
$11.5M 1.18%
169,028
-68,254
-29% -$4.87M
VZ icon
28
Verizon
VZ
$195B
$11.2M 1.15%
231,147
+4,951
+2% +$239K
CHD icon
29
Church & Dwight Co
CHD
$23.4B
$11.1M 1.14%
259,220
+400
+0.2% +$16.7K
PM icon
30
Philip Morris
PM
$297B
$10.9M 1.12%
144,822
-10,030
-6% -$814K
SYK icon
31
Stryker
SYK
$125B
$10.9M 1.12%
117,978
+920
+0.8% +$85.6K
AMGN icon
32
Amgen
AMGN
$208B
$10.7M 1.09%
66,747
+2,805
+4% +$442K
PFE icon
33
Pfizer
PFE
$143B
$10.6M 1.09%
322,050
+110
+0% +$3.5K
ORCL icon
34
Oracle
ORCL
$374B
$10.4M 1.06%
240,232
-7,554
-3% -$327K
JCI icon
35
Johnson Controls International
JCI
$88.8B
$10.3M 1.05%
194,632
+604
+0.3% +$30.7K
MSFT icon
36
Microsoft
MSFT
$3.45T
$10.1M 1.03%
247,702
-410
-0.2% -$17.9K
INTC icon
37
Intel
INTC
$455B
$9.91M 1.02%
316,860
-195
-0.1% -$6.58K
WFC icon
38
Wells Fargo
WFC
$261B
$9.73M 1%
178,819
+10,262
+6% +$555K
KRFT
39
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$9.63M 0.99%
110,587
-64,282
-37% -$4.24M
KO icon
40
Coca-Cola
KO
$377B
$9.29M 0.95%
229,233
+1,550
+0.7% +$64.8K
CTSH icon
41
Cognizant
CTSH
$24.9B
$8.97M 0.92%
143,757
-22,220
-13% -$1.31M
BAX icon
42
Baxter International
BAX
$13.5B
$8.95M 0.92%
240,477
+4,864
+2% +$184K
SBUX icon
43
Starbucks
SBUX
$120B
$8.79M 0.9%
185,570
-8,970
-5% -$403K
KSS icon
44
Kohl's
KSS
$2.17B
$8.46M 0.87%
108,144
-700
-0.6% -$47.6K
TMO icon
45
Thermo Fisher Scientific
TMO
$213B
$8.25M 0.85%
61,415
-3,695
-6% -$476K
APH icon
46
Amphenol
APH
$198B
$7.05M 0.72%
478,472
-28,040
-6% -$393K
NXPI icon
47
NXP Semiconductors
NXPI
$57.8B
$6.93M 0.71%
69,090
-117,990
-63% -$10.4M
MDY icon
48
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$6.91M 0.71%
24,930
+715
+3% +$193K
NVS icon
49
Novartis
NVS
$297B
$6.85M 0.7%
77,493
-2,817
-4% -$250K
CVX icon
50
Chevron
CVX
$392B
$6.61M 0.68%
62,916
-58,909
-48% -$6.29M

Similar funds

Chesley Taft & Associates's Q1 2015 Portfolio in Review

As of Q1 2015, Chesley Taft & Associates held 250 positions worth $975M, down 1.5% from $989M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Chesley Taft & Associates withdrew a net $38.6M in Q1 2015, closing 10 positions and reducing 103 holdings. Its most notable exit was Kellanova, an estimated $5.62M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

Against the trend, Chesley Taft & Associates opened a new position in AB InBev worth $1.06M.

  • Chesley Taft & Associates's largest Q1 2015 buy was AB InBev: 8,675 shares worth $1.06M.
  • Chesley Taft & Associates added most to IBM in Q1 2015, an estimated $9.62M increase.
  • Chesley Taft & Associates's biggest Q1 2015 reduction was NXP Semiconductors, cutting an estimated $10.4M.
  • Chesley Taft & Associates fully exited Kellanova in Q1 2015, selling an estimated $5.62M.
  • Chesley Taft & Associates's ten largest holdings make up 21% of its $975M portfolio in Q1 2015.
  • Chesley Taft & Associates opened 7 new positions and closed 10 in Q1 2015.
  • Chesley Taft & Associates's portfolio value fell 1.5% quarter-over-quarter to $975M.

Based on Chesley Taft & Associates's 13F filing for Q1 2015, filed 9 Apr 2015.